Management of Diabetic Ketoacidosis
Begin immediate treatment with isotonic saline at 15-20 mL/kg/hour for the first hour, followed by continuous intravenous regular insulin at 0.1 units/kg/hour once potassium is ≥3.3 mEq/L, and continue insulin until complete resolution of ketoacidosis regardless of glucose levels. 1
Diagnostic Criteria
DKA is confirmed when all three criteria are present: 1, 2
- Blood glucose >250 mg/dL (though euglycemic DKA can occur, particularly with SGLT2 inhibitors)
- Arterial pH <7.3 and serum bicarbonate <15 mEq/L
- Presence of ketonemia or ketonuria with elevated anion gap
Initial Laboratory Assessment
Obtain the following tests immediately: 1
- Plasma glucose, blood urea nitrogen, creatinine, serum ketones
- Electrolytes with calculated anion gap, osmolality
- Arterial blood gases, complete blood count with differential
- Urinalysis, urine ketones, electrocardiogram
- Bacterial cultures (blood, urine, throat) if infection suspected 1
Direct measurement of β-hydroxybutyrate in blood is the preferred monitoring method, as nitroprusside only detects acetoacetic acid and acetone. 1
Fluid Resuscitation
Start with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour (approximately 1-1.5 L) during the first hour to restore tissue perfusion and improve insulin sensitivity. 1 This aggressive initial fluid replacement is critical for treatment success. 1
After the first hour, adjust fluid choice based on: 1
- Hydration status
- Serum electrolyte levels
- Urine output
When serum glucose reaches 250 mg/dL, switch to 5% dextrose with 0.45-0.75% NaCl while continuing insulin therapy to prevent hypoglycemia and allow complete clearance of ketones. 1 This is a critical step—failure to add dextrose is a common cause of persistent ketoacidosis. 1
Insulin Therapy
Initiation
Do NOT start insulin if potassium <3.3 mEq/L—correct hypokalemia first to prevent life-threatening arrhythmias and respiratory muscle weakness. 1 Despite potentially normal or elevated initial potassium levels, total body potassium depletion is universal in DKA. 1
Once potassium ≥3.3 mEq/L: 1
- Start continuous IV regular insulin at 0.1 units/kg/hour (no bolus needed)
- Target glucose decline of 50-75 mg/dL per hour
- If glucose doesn't fall by 50 mg/dL in the first hour, check hydration; if adequate, double the insulin infusion rate hourly until steady decline achieved
Critical Insulin Management Principle
Continue insulin infusion until complete resolution of ketoacidosis (pH >7.3, bicarbonate ≥18 mEq/L, anion gap ≤12 mEq/L) regardless of glucose levels. 1 Premature termination of insulin before ketosis resolves is a leading cause of DKA recurrence. 1
Alternative for Mild-Moderate DKA
For uncomplicated mild-to-moderate DKA in alert patients, subcutaneous rapid-acting insulin analogs combined with aggressive fluid management are equally effective, safer, and more cost-effective than IV insulin. 1 However, continuous IV insulin remains standard for critically ill and mentally obtunded patients. 1
Electrolyte Management
Potassium Replacement
This is critical—inadequate potassium monitoring and replacement is a leading cause of DKA mortality. 1
Potassium replacement protocol: 1
- If K+ <3.3 mEq/L: Hold insulin, aggressively replace potassium until ≥3.3 mEq/L
- If K+ 3.3-5.5 mEq/L: Add 20-30 mEq/L potassium to IV fluids (use 2/3 KCl and 1/3 KPO₄) once adequate urine output confirmed
- If K+ >5.5 mEq/L: Withhold potassium initially but monitor closely, as levels will drop rapidly with insulin therapy
- Target serum potassium 4-5 mEq/L throughout treatment
Bicarbonate
Bicarbonate is NOT recommended for pH >6.9-7.0. 1 Studies show no benefit in resolution time or outcomes, and it may worsen ketosis, cause hypokalemia, and increase cerebral edema risk. 1
Monitoring During Treatment
Draw blood every 2-4 hours to measure: 1
- Serum electrolytes, glucose, blood urea nitrogen, creatinine
- Osmolality and venous pH (typically 0.03 units lower than arterial pH)
- Anion gap to monitor acidosis resolution
Check blood glucose every 1-2 hours until stable, then every 4 hours. 3
Monitor for cerebral edema, particularly in children and with overly rapid osmolality correction (should not exceed 3 mOsm/kg/hour). 3
Resolution Criteria
DKA is resolved when ALL of the following are met: 1
- Glucose <200 mg/dL
- Serum bicarbonate ≥18 mEq/L
- Venous pH >7.3
- Anion gap ≤12 mEq/L
Target glucose 150-200 mg/dL until these resolution parameters are achieved. 1
Transition to Subcutaneous Insulin
Administer basal insulin (intermediate or long-acting) 2-4 hours BEFORE stopping IV insulin infusion to prevent recurrence of ketoacidosis and rebound hyperglycemia. 1 This overlap period is essential. 1
Once patient can eat, start multiple-dose schedule using combination of short/rapid-acting and intermediate/long-acting insulin. 1
Treatment of Precipitating Causes
Identify and treat underlying triggers: 1
- Infection (most common—administer appropriate antibiotics)
- Myocardial infarction, cerebrovascular accident
- Insulin discontinuation or inadequacy
- Pancreatitis, trauma
- SGLT2 inhibitors must be discontinued 3-4 days before any planned surgery to prevent euglycemic DKA 1
Common Pitfalls to Avoid
Critical errors that lead to complications or treatment failure: 1
- Interrupting insulin when glucose falls while ketoacidosis persists—this is a common cause of worsening ketosis
- Failing to add dextrose when glucose <250 mg/dL while continuing insulin
- Premature termination of insulin therapy before complete ketosis resolution
- Inadequate potassium monitoring and replacement—a leading cause of mortality
- Overzealous treatment without glucose supplementation leading to hypoglycemia
- Overly rapid correction of osmolality (>3 mOsm/kg/hour) increasing cerebral edema risk
Discharge Planning
Before discharge, ensure: 1
- Identification of outpatient diabetes care providers
- Patient understanding of diabetes diagnosis and glucose monitoring
- Knowledge of home glucose goals and when to call healthcare professional
- Schedule follow-up appointments prior to discharge to increase attendance likelihood